The Spectranetics

Cardiovascular health is at the very core of their quality of life. Thankfully, an increasing number of cardiovascular surgeries are minimally invasive procedures. But minimizing the impact on patients requires an enormous degree of skill on the part of physicians—and an enormous degree of sophistication in the tools and techniques they rely upon. Spectranetics provides expert tools, training and support designed to help successfully manage every cardiac lead, modify all plaque and eradicate restenosis and amputation, saving time, money and lives. The company was founded on and remains dedicated to product innovation, continually investigating new ways to meet the demands of the most challenging minimally invasive cardiac lead removal and vascular intervention procedures.

Guy Childs

Vice President and CFO

1 past transactions

AngioScore

Acquisition in 2014
AngioScore Inc. develops, manufactures and markets the AngioSculpt Scoring Balloon Catheter for both the coronary and peripheral interventional markets. Designed specifically to address the limitations of conventional angioplasty balloon catheters, AngioSculpt combines a semi-compliant balloon with an innovative nitinol scoring element.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.